Recently, the Bausch+Ströbel Shanghai Representative Office has been officially established, opening a new chapter of localized development.

Together with our partner Rieckermann, we can deliver more efficient and responsive reactions to customers’ needs along with their whole production process.

The founding of the Shanghai Representative Office is an important strategic move based on the huge potential and development opportunities of the Chinese market, and a key step to fulfill the company’s global vision to become a trusted partner in global pharmaceutical manufacturing.

About Bausch+Ströbel

Founded in Germany, Bausch+Ströbel specializes in providing integrated solutions for the filling and packaging of sterile injectables for pharmaceutical companies. Since its establishment in 1967, Bausch+Ströbel has been collaborating closely with customers to develop customized solutions tailored to their needs. With a strong commitment to product quality, technological innovation and customer-centricity, Bausch+Ströbel builds a stable, reliable and flexible safety foundation for pharmaceutical production. Through continuous efforts, the company has made outstanding contributions to ensuring the safe production, stable supply and universal accessibility of medicines worldwide.

Bausch+Ströbel has more than 3000 employees globally and is continuously expanding its global footprint. Its equipment is used in over 100 countries, with representative offices in more than 50 nations. To further advance its global strategy, deepen its presence in China, Bausch+Ströbel has officially set up its China Representative Office.

Message from Headquarters

Mr. Markus Ströbel, a member of executive board sent a special message:

“China’s pharmaceutical market is developing rapidly with broad prospects, and it has always been one of Bausch+Ströbel’s most important markets.

Together with our partner Rieckermann we can deliver more efficient and responsive reactions to your needs along your whole production processes. With the establishment of the representative office, we are confident in growing together with the Chinese pharmaceutical industry and contributing to its high-quality, global development.”